The ontogeny of endothelial progenitor cells through flow cytometry

Current Opinion in Hematology

Volumn 18, Issue 3, 2011, Pages 166-170

  Mund, Julie A ^a,b   Case, Jamie ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

endothelial progenitor cell; hematopoietic stem cell; polychromatic flow cytometry

Indexed keywords

ATORVASTATIN; BEVACIZUMAB; GEMCITABINE; OXALIPLATIN;

ARTICLE; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; COLORECTAL CANCER; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; HUMAN; LUNG DISEASE; METABOLIC SYNDROME X; ONTOGENY; PANCREAS CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; SLEEP APNEA SYNDROME;

ENDOTHELIAL CELLS; FLOW CYTOMETRY; HUMANS; PHENOTYPE;

EID: 79955013396     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e328345a16a     Document Type: Article

References (33)

1. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275:964-967. (Pubitemid 27087709)
2. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95:952-958. (Pubitemid 30062717)
3. Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004; 104:2752-2760. (Pubitemid 39434958)
4. Case J, Mead LE, Bessler WK, et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007; 35:1109-1118. (Pubitemid 46921310)
5. Estes ML, Mund JA, Ingram DA, Case J. Identification of endothelial cells and progenitor cell subsets in human peripheral blood. Curr Protoc Cytom 2010; Chapter 9:9.33.1 -9.33.11.
6. Schmidt-LuckeC, FichtlschererS, Aicher A, et al. Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol. PLoS One 2010; 5:e13790.
7. Masouleh BK, Baraniskin A, Schmiegel W, Schroers R. Quantification of circulating endothelial progenitor cells in human peripheral blood: establish ing a reliable flow cytometry protocol. J Immunol Methods 2010; 357 (1-2):38-42.
8. Estes ML, Mund JA, Mead LE, et al. Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential. Cytometry A 2010; 77:831-839.
9. Kheirandish-Gozal L, Bhattacharjee R, Kim J, et al. Endothelial progenitor cells and vascular dysfunction in children with obstructive sleep apnea. Am J Respir Crit Care Med 2010; 182:92-97.
10. Navarro-Sobrino M, Rosell A, Hernandez-Guillamon M, et al. Mobilization, endothelial differentiation and functional capacity of endothelial progenitor cells after ischemic stroke. Microvasc Res 2010; 80:317-323.
11. Puls M, Schroeter MR, Steier J, et al. Effect of smoking cessation on the number and adhesive properties of early outgrowth endothelial progenitor cells. Int J Cardiol [Epub ahead of print].
12. Reinhard H, Jacobsen PK, Lajer M, et al. Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes. Diabetologia 2010; 53:2129-2133.
13. Padfield GJ, Tura O, Haeck ML, et al. Circulating endothelial progenitor cells are not affected by acute systemic inflammation. Am J Physiol Heart Circ Physiol 2010; 298:H2054-H2061.
14. OToole TE, Hellmann J, Wheat L, et al. Episodic exposure to fine particulate air pollution decreases circulating levels of endothelial progenitor cells. Circ Res 2010; 107:200-203.
15. Jialal I, Devaraj S, Singh U, Huet BA. Decreased number and impaired function-ality of endothelial progenitor cells in subjects with metabolic syndrome: implica tions for increased cardiovascular risk. Atherosclerosis 2010; 211:297-302.
16. Schmidt-Lucke C, Fichtlscherer S, Rossig L, et al. Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy. Atherosclerosis 2010; 211:249-254.
17. Fortini C, Toffoletto B, Fucili A, et al. Circulating stem cell vary with NYHA stage in heart failure patients. J Cell Mol Med 2010 [Epub ahead of print].
18. Jie KE, van der Putten K, Bergevoet MW, et al. Short-and long-term effects of erythropoietin treatment on endothelial progenitor cell levels in patients with cardiorenal syndrome. Heart 2011; 97:60-65.
19. Bogoslovsky T, Chaudhry A, Latour L, et al. Endothelial progenitor cells correlate with lesion volume and growth in acute stroke. Neurology 2010; 75:2059-2062.
20. Briguori C, Testa U, Riccioni R, et al. Correlations between progression of coronary artery disease and circulating endothelial progenitor cells. FASEB J 2010; 24:1981-1988.
21. Lev EI, Leshem-Lev D, Mager A, et al. Circulating endothelial progenitor cell levels and function in patients who experienced late coronary stent thrombosis. Eur Heart J 2010; 31:2625-2632.
22. Kuroi A, Imanishi T, Suzuki H, et al. Clinical characteristics of patients with kawasaki disease and levels of peripheral endothelial progenitor cells and blood monocyte subpopulations. Circ J 2010; 74:2720-2725.
23. Vizio B, Novarino A, Giacobino A, et al. Pilot study to relate clinical outcome in pancreatic carcinoma and angiogenic plasma factors/circulating mature/progenitor endothelial cells: preliminary results. Cancer Sci 2010; 101:2448-2454.
24. Blann AD, Balakrishnan B, Shantsila E, et al. Endothelial progenitor cells and circulating endothelial cells in early prostate cancer: a comparison with plasma vascular markers. Prostate 2010 [Epub ahead of print].
25. Ronzoni M, Manzoni M, Mariucci S, et al. Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevaci-zumab-based first-line treatment in advanced colorectal cancer patients. Ann Oncol 2010; 21:2382-2389.
26. Su Y, Zheng L, Wang Q, et al. Quantity and clinical relevance of circulating endothelial progenitor cells in human ovarian cancer. J Exp Clin Cancer Res 2010; 29:27.
27. Jie KE, Lilien MR, Goossens MH, et al. Reduced endothelial progenitor cells in children with hemodialysis but not predialysis chronic kidney disease. Pediatrics 2010; 126:e990-e993.
28. Quaranta N, Ramunni A, De Luca C, et al. Endothelial progenitor cells in sudden sensorineural hearing loss. Acta Otolaryngol 2010 [Epub ahead of print].
29. Caramori G, Rigolin GM, Mazzoni F, et al. Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD. Thorax 2010; 65:554-555.
30. Mandraffino G, Sardo MA, Riggio S, et al. Smoke exposure and circulating progenitor cells: evidence for modulation of antioxidant enzymes and cell count. Clin Biochem 2010; 43:1436-1442.
31. Sala E, Villena C, Balaguer C, et al. Abnormal levels of circulating endothelial progenitor cells during exacerbations of COPD. Lung 2010; 188:331-338.
32. Van Craenenbroeck EM, Hoymans VY, Beckers PJ, et al. Exercise training improves function of circulating angiogenic cells in patients with chronic heart failure. Basic Res Cardiol 2010; 105:665-676.
33. Arnold C, Wenta D, Muller-Ehmsen J, et al. Progenitor cell number is correlated to physical performance in obese children and young adolescents. Cardiol Young 2010; 20:381-386.